Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?

Autosomal dominant polycystic kidney disease (ADPKD) accounts for 8 –10% of end-stage chronic kidney disease (CKD) patients worldwide. In the last decade, the advanced knowledge in genetics and molecular pathob...

Source: BMC Nephrology - October 22, 2018 Category: Urology & Nephrology Authors: Antonio Pisani, Eleonora Riccio, Dario Bruzzese and Massimo Sabbatini Tags: Research article Source Type: research